We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App





Siemens Showcases Broad Portfolio of Integrated IVD Solutions at EUROMEDLAB Munich

By LabMedica International staff writers
Posted on 11 Apr 2022
Print article
Image: epoc® Blood Analysis System (Photo courtesy of Siemens Healthineers)
Image: epoc® Blood Analysis System (Photo courtesy of Siemens Healthineers)

Siemens Healthineers (Erlangen, Germany) showcased its broad portfolio of integrated IVD solutions at EUROMEDLAB 2022 which was held 10th-14th April 2022 in Munich, Germany.

At EUROMEDLAB Munich, Siemens demonstrated it automation solutions for labs of all sizes that are fully scalable, innovative, and customized for individual workflows. Siemens demonstrated how labs could achieve open, one-touch, end-to-end testing with its Aptio Automation solution and drive open, one-touch sample preparation for multidisciplinary labs with its Atellica Task Targeted Automation solution. The company also demonstrated how its Atellica Integrated Automation solution could streamline the biggest chemistry and immunoassay workloads for laboratories.

The company showcased its two new high-volume hematology analyzers - Atellica HEMA 570 and 580 - designed to meet the hematology testing needs of today’s high-volume labs. Sharing fast throughput and an identical footprint, both instruments are intended to pair with advanced informatics and automation solutions to suit diverse workflow requirements and drive efficiencies across labs and networks. Each delivers a range of analytical capabilities, including an 8-part white blood cell differential, with the Atellica HEMA 580 Analyzer offering an expanded menu complete with optical platelet and reticulocyte testing. In addition, Siemens highlighted its epoc Blood Analysis System with epoc NXS Hos, the market-first Android powered patient-side testing solution. epoc is a handheld, wireless solution to enable comprehensive blood analysis testing at the patient’s side on a single room temperature test card, with results in less than a minute.

Siemens also displayed the Dimension EXL 200 Integrated Chemistry System which can simplify operations with an integrated chemistry and immunoassay analyzer in a compact footprint. Also on display were the Sysmex CN-3000 and CN-6000 fully automated, mid- and high-volume coagulation analyzers that are designed to tackle big lab challenges. In addition, Siemens exhibited the new Atellica DCA connected, scalable, and portable analyzer that can collect actionable HbA1c and ACR results in minutes, alongside the Atellica CI 1900 System which is being developed for lower- to mid-volume laboratories. Among its high-performing assays, Siemens showcased the breadth and depth of its clinical menu from cardiac and allergy testing to dedicated plasma protein/FLC to real-time PCR testing for SARS-CoV-2, new preeclampsia markers and more.

Related Links:
Siemens Healthineers 

New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
New
Human Thyroglobulin Assay
Human Thyroglobulin CLIA Kit
New
Centrifuge
Hematocrit Centrifuge 7511M4

Print article

Channels

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Pathology

view channel
Image: The study examined the influence of pre-analytical conditions on cell-free microRNA stability in blood plasma samples (Photo courtesy of 123RF)

Pre-Analytical Conditions Influence Cell-Free MicroRNA Stability in Blood Plasma Samples

Scientists worldwide are working to enhance the quality of diagnostics and prognosis for various diseases, including cancer, by analyzing different body fluids such as blood, urine, and saliva.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.